Martine Prütz Nørskov

Dr. Martine Prütz Nørskov

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2018 in Lupus
Verified
Journal Article
Closed access
MNMartine Prütz Nørskov
Martine Prütz Nørskov
Sören MöllerSören Möller
Sören Möller
ABA Bygum
A Bygum
AVA Voss
A Voss
MBM Bliddal
M Bliddal
Objectives: The objectives of this paper are to describe the epidemiology of cutaneous lupus erythematosus (CLE) and its subtypes in Denmark, and to investigate the probability of receiving a subsequent diagnosis of systemic lupus erythematosus (SLE) and the related time course. Methods: A nationwide registry-based cohort study was conducted in Denmark based on data from the Danish National Patient Registry from 1998 to 2013 using International Classification of Diseases, Revision 10. Results: We identified 2380 patients with CLE. The annual incidence rate (IR) of CLE was 2.74/100,000 with a female:male ratio of 4:1. During 12,047 person-years of follow-up, 8% were diagnosed with SLE. The probability of receiving a subsequent diagnosis of SLE was 12.9% after 10 years taking death as a competing risk into consideration, and the probability was highest among women and patients diagnosed with subacute CLE. The median time until a diagnosis of SLE was 2.05 years. Conclusions: This is the first nationwide study on CLE in Denmark. Although we found the annual IR of CLE and the risk of receiving an additional diagnosis of SLE to be lower than previously described, continued monitoring and thorough information for patients with CLE is important due to the inherent risk of SLE.

17 April 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
MNMartine Prütz Nørskov
Martine Prütz Nørskov
TMThormod Mønsted
Thormod Mønsted
NKNina Kimer
Nina Kimer
MDMorten Damgaard
Morten Damgaard
SMSøren Møller
Søren Møller
Background: Patients with cirrhosis often develop hyperdynamic circulation with increased cardiac output, heart rate, and redistribution of the circulating volume with expanded plasma volume (PV). PV determination is part of the evaluation of patients with cirrhosis, but gold-standard methods are invasive, expensive, and time-consuming. Therefore, other estimations of PV would be preferable, and the aim of this study was therefore to study if PV, as assessed by a simplified algorithm based on hematocrit and weight, can replace the gold-standard method. Methods: We included 328 patients with cirrhosis who had their PV assessed by the indicator dilution technique as the gold-standard method (PVI-125). Actual PV was estimated as PVa = (1 − hematocrit)·(a + (b·body weight)). Ideal PV was estimated as PVi = c · body weight, where a, b, and c are constants. Results: PVI-125, PVa, and PVi were 3.99 ± 1.01, 3.09 ± 0.54, and 3.01 ± 0.65 (Mean ± SD), respectively. Although PVI-125 correlated significantly with PVa (r = 0.72, p < 0.001), a Bland–Altman plot revealed wide limits of confidence. Conclusions: The use of simplified algorithms does not sufficiently estimate PV and cannot replace the indicator dilution technique.

4 July 2026 in Tissue Barriers
Verified
Journal Article
Open access
MNMartine Prütz Nørskov
Martine Prütz Nørskov
ECElisabeth Præstekjær Cramer
Elisabeth Præstekjær Cramer
ULUlrich Lindberg
Ulrich Lindberg
AHAdam Espe Hansen
Adam Espe Hansen
JCJonathan Frederik Carlsen
Jonathan Frederik Carlsen
SCStig Præstekjær Cramer
Stig Præstekjær Cramer
Central nervous system (CNS) relapse is a serious complication of diffuse large B-Cell lymphoma (DLBCL), often associated with poor clinical outcomes. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) enables detection of subtle blood-brain barrier (BBB) leakage. We assessed BBB permeability, using the Patlak model, in 63 patients with DLBCL without CNS involvement and 11 healthy controls using DCE-MRI, and investigated associations with established risk factors for CNS relapse. Patients with high risk of CNS relapse (CNS-IPI ≥4) demonstrated near-significant increased BBB permeability in cortical gray matter (GM) compared with both low-risk patients (p = 0.053) and healthy controls (p = 0.02). BBB permeability in cortical GM and in cerebral white matter (WM) correlated positively with age (p < 0.001). After adjusting for age, patients with kidney and/or adrenal involvement exhibited significantly higher BBB permeability in cortical GM (p = 0.04). Furthermore, plasma albumin levels were inversely correlated with BBB permeability in both GM (p = 0.003) and WM (p = 0.005). These findings indicate that subclinical BBB dysfunction may contribute to CNS vulnerability in DLBCL, potentially predisposing patients to relapse even before CNS involvement occurs. The observed age-related increase in BBB permeability is consistent with previous reports and may represent an independent risk for CNS relapse. Collectively, these results suggest that BBB imaging could improve CNS risk stratification in DLBCL. Prospective studies are warranted to determine whether early BBB alterations can predict CNS relapse in individual patients.